NexLife vs Ro Body
How NexLife and Ro Body compare on price, medication type, clinical oversight, and pharmacy transparency — with the trade-offs and who each may suit.
| NexLife | Ro Body | |
|---|---|---|
| From / month | $186/mo* | $349+/mo |
| Pricing model | Flat, dose-independent | Varies — see provider |
| Medication type | Compounded tirzepatide | Brand (Zepbound/Mounjaro) |
| FDA status | Not FDA-approved (compounded) | FDA-approved |
| Clinical oversight | MD/DO-supervised | MD-led |
| Pharmacy / fulfillment | 503A & 503B (six disclosed) | Manufacturer / retail pharmacy |
| What's included | Meds, visits, labs, coaching | Brand medication, provider visits, insurance prior-auth assistance |
| Insurance | Cash-pay (HSA/FSA) | Insurance prior-auth support |
Pricing verified as of June 2026 — confirm current figures with each provider. Compounded medications are not FDA-approved.
Clinical model
NexLife uses MD/DO-supervised care with included lab review and titration support. Ro Body operates a md-led model (brand (zepbound/mounjaro)). Eligibility and any prescription are determined by a licensed clinician in both cases, and outcomes are not guaranteed.
Pharmacy & fulfillment
NexLife discloses six partner pharmacies across the 503A and 503B pathways and offers certificates of analysis on request. Ro Body fulfillment: Manufacturer / retail pharmacy. Compounded products from either pathway are not FDA-approved — see 503A vs 503B.
Strengths and trade-offs
NexLife
- Flat, dose-independent pricing ($186/mo, 12-mo plan)
- MD/DO-supervised under a named Medical Director
- Six disclosed partner pharmacies (503A + 503B)
- Labs and Care360 coaching included; unlimited messaging
- LegitScript-certified
- Compounded only — not FDA-approved
- Cash-pay with HSA/FSA only — no insurance billing
- No brand-name Wegovy®/Zepbound®
- Results vary by patient; eligibility not guaranteed
Ro Body
- FDA-approved brand-name tirzepatide
- Help navigating insurance prior authorization
- Established national telehealth brand
- Higher cash cost than compounded
- Cost depends heavily on coverage
- No flat compounded option
Who each may be best for
NexLife may suit you if you want predictable flat pricing that doesn't rise with dose, MD/DO oversight, disclosed pharmacies, and bundled labs/coaching — and you're comfortable with compounded medication (not FDA-approved) paid cash-pay.
Ro Body may suit you if you want an FDA-approved brand-name product and/or insurance pathways, and are comfortable with a higher or coverage-dependent cost.
Questions
Is NexLife or Ro Body cheaper?
As of June 2026, NexLife starts at $186/month flat. Ro Body is listed from $349+/mo. Compare total annual cost including visits and labs, not just the headline price. Compounded tirzepatide is not FDA-approved. See NexLife pricing
What's the main difference between NexLife and Ro Body?
NexLife is flat-rate compounded tirzepatide with MD/DO oversight and disclosed 503A/503B pharmacies; Ro Body is brand (zepbound/mounjaro) with a md-led model. Choose based on whether you want compounded vs brand, flat vs variable pricing, and your insurance situation.
Is compounded tirzepatide FDA-approved?
No. Compounded tirzepatide is not FDA-approved. Only brand-name Mounjaro (type 2 diabetes) and Zepbound (chronic weight management), made by Eli Lilly, are FDA-approved. Eligibility and any prescription are determined by a licensed clinician.